Maternal obesity: improving pregnancy outcomes
Priscilla M Nodine1, Marie Hastings-Tolsma
1School of Medicine, Department of Obstetrics and Gynecology, University of Colorado, Denver, Aurora, CO, USA. priscilla.nodine@ucdenver.edu
Approximately 30% of pregnant women are obese (body mass index [BMI] ≥ 30) and are at risk for adverse pregnancy outcomes. In this article, we review the literature on select obstetrical risks associated with maternal obesity and assess the recommended prevention and management strategies. The selected risks include infertility, fetal anomalies, gestational hypertensive diseases, gestational diabetes, intrauterine fetal death, cesarean birth, macrosomia, and long-term risks of adult disease for the fetus. The causes of these adverse outcomes include maternal body habitus, the proinflammatory state of obesity, and metabolic dysfunction. We also discuss how nurses, nurse practitioners, and nurse-midwives can make a difference in the prenatal care and immediate pregnancy outcomes of pregnant women with obesity and influence future health for these women and their children.
Approximately 30% of pregnant women are obese (body mass index [BMI] ≥ 30) and are at risk for adverse pregnancy outcomes. In this article, we review the literature on select obstetrical risks associated with maternal obesity and assess the recommended prevention and management strategies. The selected risks include infertility, fetal anomalies, gestational hypertensive diseases, gestational diabetes, intrauterine fetal death, cesarean birth, macrosomia, and long-term risks of adult disease for the fetus. The causes of these adverse outcomes include maternal body habitus, the proinflammatory state of obesity, and metabolic dysfunction. We also discuss how nurses, nurse practitioners, and nurse-midwives can make a difference in the prenatal care and immediate pregnancy outcomes of pregnant women with obesity and influence future health for these women and their children.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Obesity
Drug Dosing: Obese Patients
Mitral Valve Prolapse III: Nursing Management
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution


